Mariposa Therapeutics
PrivateLast Round
Seed
Mar 11, 2026
Total Funding Raised
$1M
Company Overview
Mariposa Therapeutics is a biotechnology company developing a first-in-class small molecule, MP5219, as a topical treatment for Epidermolysis Bullosa Simplex (EBS).
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Revenue Share, Hardware Sales
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Mariposa Therapeutics Comparables
Compare Mariposa Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| BioMendics | 83% | |
| Paradigm Therapeutics, Inc. | 77% | |
| Aegle Therapeutics Corp | 76% | |
Mariposa Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Mar 11, 2026 |
Mariposa Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Development Bank of Wales | Seed |
| DEBRA Research gGmbH | Seed |
Mariposa Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Mariposa Therapeutics's valuation, stock price, and market status.